APLT:US
$0.353
-1.997%

Applied Therapeutics Inc.
News & Events

Last updated: Jun 1, 2025, 2:49 PM ET

  1. Applied Therapeutics Presents Full 12-Month Clinical Results and New Topline Data from INSPIRE Phase 2/3 Trial of Govorestat in CMT-SORD in Late-Breaking Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

    GlobeNewswire MAY 18, 2025 7:28 AM EDT
    S lowing of progression of disease observed via MRI at 24 months Improvements in outcom...
    READ ARTICLE
  2. Applied Therapeutics Reports First Quarter 2025 Financial Results

    GlobeNewswire MAY 13, 2025 5:00 PM EDT
    - Company to present full 12-month clinical data and new topline 18-month and 24-month data from ...
    READ ARTICLE
  3. Applied Therapeutics Announces Acceptance of Late-Breaking Abstract for Oral Presentation at the Peripheral Nerve Society 2025 Annual Meeting

    GlobeNewswire MAY 9, 2025 5:00 PM EDT
    NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the “...
    READ ARTICLE
  4. NET Power Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 17, 2025 Deadline to file Lead Plaintiff Motion

    GlobeNewswire APR 22, 2025 6:12 PM EDT
    Investors can contact the law firm at no cost to learn more about recovering their lo...
    READ ARTICLE
  5. Applied Therapeutics Reports Fourth Quarter and Year-end 2024 Financial Results

    GlobeNewswire APR 14, 2025 5:50 PM EDT
    -  Appointed John H. Johnson as Executive Chairman; Todd F. Baumgartner, MD, MPH as Chi...
    READ ARTICLE
  6. Applied Therapeutics Files Form 12b-25 with the Securities and Exchange Commission

    GlobeNewswire MAR 31, 2025 7:10 AM EDT
    NEW YORK, March 31, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT) (the ...
    READ ARTICLE
  7. Applied Therapeutics Appoints Todd F. Baumgartner, MD, MPH as Chief Regulatory Officer

    GlobeNewswire MAR 19, 2025 7:00 AM EDT
    NEW YORK, March 19, 2025 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biophar...
    READ ARTICLE
  8. APLT DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Applied Therapeutics, Inc. Investors to Secure Counsel Before Important February 18 Deadline in Securities Class Action - APLT

    Newsfile FEB 18, 2025 10:36 PM EST
    New York, New York--(Newsfile Corp. - February 18, 2025) - WHY: Rosen Law Firm, a global invest...
    READ ARTICLE
  9. FINAL REMINDER APLT DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Applied Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit

    Newsfile FEB 18, 2025 4:00 PM EST
    New York, New York--(Newsfile Corp. - February 18, 2025) - Bronstein, Gewirtz & Grossman, LLC...
    READ ARTICLE
  10. Applied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT

    GlobeNewswire FEB 18, 2025 2:22 PM EST
    NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in App...
    READ ARTICLE

Upcoming Events

Get notified of Applied Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement (Unconfirmed)

    Aug 13, 2025
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available